Connie Chen, MD
Chief Operating Officer
Lyra uses validated clinical measures, such as the PHQ-9 and the GAD-7, to assess symptom improvement for anxiety, depression, and other common mental health issues. Reliable clinical change is a 6-point difference on the PHQ-9 and a 4-point change on the GAD-7.
Learn more about our impactOnly 24% of members who receive care through health plans demonstrate reliable clinical improvement.
88% of Lyra’s members improve or recover.
Evidence-based treatments, or EBTs, are methods that have been proven effective at reducing symptoms and overall functioning, as defined by the Division of Clinical Psychology of the APA (Chambless & Hollon, 1998; Tolin et al., 2015). Lyra only works with providers who provide these treatments.
At Lyra, we use “reliable clinical improvement” to measure change, which means that an individual in treatment has improved enough on a measure of clinical symptoms that we don’t believe the change can be accounted for by normal variation in scores or measurement error.
Thousands of providers across all 50 states offer evidence-based treatments and are specifically recruited to give your employees the highest quality care and diverse options for race/ethnicity, LGBTQ sensitivity, and clinical focus.
Learn more about the Lyra networkWith thousands of members using Lyra and the largest network of evidence-based providers, we can glean some amazing insights into treatment and provider effectiveness. Read the latest findings from our clinical research team.
Learn more about Lyra Clinical ResearchLyra Clinical Research is a team of doctorate-level clinicians and data scientists that delves into key questions about mental health.
Chief Operating Officer
Vice President, Clinical Product
Vice President, Psychiatry & Complex Care
Lead Clinical Researcher